Human health news

U of T Engineering is a leader in health care engineering. Together with doctors, medical researchers, policymakers and industry, we are helping people around the world live longer, healthier lives.

University Professor Michael Sefton (IBBME, ChemE) has received $1.1M in research funding to advance treatment for type 1 diabetes that involves transplanting pancreatic cells under the skin. (Credit: Neil Ta)

Michael Sefton receives $1.1M from JDRF for type 1 diabetes research

Funding supports investigation of experimental treatment that involves transplanting healthy pancreatic cells into patients living with the disease

University Professor Peter Zandstra (IBBME) will be receiving the Scale-Up and Manufacturing of Cell-Based Therapies Award from Engineering Conferences International. (Credit: Neil Ta).

Peter Zandstra recognized for contributions to development and commercialization of stem cell-based therapies

IBBME University Professor to receive Scale-Up and Manufacturing of Cell-Based Therapies Award at Engineering Conferences International

University Professor Michael Sefton (IBBME, ChemE), University of Toronto biomedical engineering University Professor Michael Sefton (IBBME, ChemE) has been awarded the Lifetime Achievement Award from the Tissue Engineering & Regenerative Medicine International Society. (Credit: Neil Ta)

Michael Sefton to receive Lifetime Achievement Award from the Tissue Engineering & Regenerative Medicine International Society

The award, issued by the organization’s Americas chapter, recognizes immense contributions to the fields of tissue engineering and regenerative medicine

U of T doctoral researchers Iliya Sigal (right) and Dene Ringuette are part of a team that designed a miniature microscope that could open new doors for epilepsy and seizure monitoring and treatment. (Credit: Luke Ng).

Battery-sized microscope gives new insights into brain activity during seizures

Technique could offer insights into what causes epilepsy, and lead to more effective treatments for more than 15,000 Canadians diagnosed each year

Vahid Raeesi (Photo: Tyler Irving)

Multi-functional, modular nanoparticles could help fight cancer

New cancer-fighting nanoparticles developed at U of T Engineering carry out multiple functions to kill cancer cells while leaving healthy ones alone. They consist of a gold nanorod core (yellow, at left) surrounded by smaller gold spheres and linked via strands of DNA containing anti-cancer drug (red). The spheres are coated with a polymer film […]

A sign indicating the location of an automated external defibrillator (AED) is pictured. Research led by U of T Engineering Professor Tim Chan showed that up to 30 per cent of the time, AEDs are locked inside closed buildings when someone suffers cardiac arrest in a public place. (Credit: U of T Engineering)

Many life-saving defibrillators behind locked doors during off-hours, study finds

A study led by U of T Engineering researchers shows that automated external defibrillators (AEDs) are inacessible up to 30 per cent of the time.

U of T researchers Sonya MacParland (right) and Kim Tsoi (IBBME PhD 1T6) are the lead authors on a four-year study that showed how the liver and spleen trapped cancer nanomedicine, preventing them from reaching their intended targets. (Photo: Peter Church)

Understanding a key roadblock behind nanoparticle cancer drug delivery

A new paper from Prof. Warren Chan and colleagues is shedding light on how the liver interacts with nanoparticles

University of Toronto professor John E. Davies (IBBME) is part of a research team that has engineered stem cells to improve antibody therapy used to treat conditions such as Crohn’s Disease and certain cancers. (Photo: Luke Ng)

Engineering stem cells to enhance antibody therapy

Canadian researchers first to demonstrate that stem cells can be used to deliver antibodies more effectively than administration of the antibodies themselves

Professor Paul Yoo (right) and PhD candidate Zainab Moazzam are part of a team working on a novel therapy for overactive bladder disorder, an affliction faced by 18 per cent of Canadian adults. (Credit: Luke Ng)

Paul Yoo awarded AGE-WELL research grant for treating overactive bladder disorder

Researchers recently discovered a neural mechanism that can inhibit bladder function by applying electrical pulses to peripheral nerves